The pet gut microbiome testing market size was valued at USD 318.06 million in 2025 and is projected to grow from USD 337.27 million in 2026 to USD 546.36 million by 2034, registering a CAGR of 6.22% during the forecast period (2026–2034). North America dominated the pet gut microbiome testing marketwith a marketshare of 39.04% in 2025.
Pet gut microbiome testing involves analyzing microorganisms present in a pet’s digestive tract to assess gut health, detect microbial imbalances, and provide insights into digestion, immunity, metabolism, and overall well-being. These tests use advanced DNA sequencing technologies to generate personalized health reports and nutritional recommendations for companion animals. They are increasingly adopted in veterinary diagnostics and personalized nutrition programs.
The pet gut microbiome testing market demand is driven by rising pet ownership, growing awareness of preventive healthcare, and higher spending on companion animal wellness. Advances in sequencing technologies and expanding veterinary diagnostic services are contributing to pet gut microbiome testing market growth.
Download a Free Sample to Explore Detailed Market Insights
The pet gut microbiome testing market is indirectly exposed to supply chain disruptions due to its dependence on sequencing reagents, laboratory consumables, sample collection kits, and logistics networks. Disruptions in the supply of molecular biology reagents, diagnostic components, and international transportation can delay sample processing, increase operational costs, and extend testing turnaround times across veterinary laboratories. These challenges also affect research collaborations, product launches, and the availability of advanced microbiome testing services, influencing market expansion on a global scale. Despite these disruptions, the market is expected to follow a capacity-constrained recovery, supported by localized sourcing, expanding laboratory infrastructure, and strengthened supply chain resilience.
Pet owners are increasingly shifting from reactive treatment to preventive healthcare, making gut microbiome testing an important tool for early health assessment and personalized wellness management. This transition is encouraging veterinarians to incorporate microbiome analysis into routine health evaluations for companion animals, particularly dogs and cats.
Advancements in artificial intelligence and next-generation sequencing are transforming pet gut microbiome testing from basic microbial profiling to predictive health analytics. This transition enables more accurate interpretation of microbiome data, supports personalized nutrition planning, and improves clinical decision-making for veterinarians. This results in broader adoption of data-driven microbiome solutions across veterinary diagnostics and pet wellness services.
The pet gut microbiome testing market forecasts sustained investments toward expanding microbiome research, enhancing diagnostic capabilities, and developing personalized nutrition and health monitoring solutions for companion animals.
Pet Gut Microbiome Testing Market Investment and Funding Analysis, 2026
Vetic
USD 40 Million
In June 2026, Vetic raised funding led by Bessemer Venture Partners with participation from Greenoaks Capital, Lachy Groom, and JSW Ventures. The investment will expand veterinary clinics, diagnostics, and digital pet healthcare services, indirectly supporting growth in companion animal diagnostics.
Aviwell
USD 12.58 Million
In January 2026, Aviwell secured a Series A round from Blue Revolution Fund, Blast.Club, SWEN Capital Partners, Elaia, and MFS Investment Management to scale its AI-driven microbiome discovery platform.
Increasing Humanization of Pets and Advancements in Next-generation Sequencing Drives Market
The growing humanization of pets is encouraging owners to invest in advanced diagnostic solutions that support long-term health and quality of life. Pet owners are increasingly willing to spend on premium veterinary services, including gut microbiome testing, to identify health risks early and optimize nutrition. This shift is driving demand for microbiome-based diagnostics among veterinary clinics and pet wellness providers while expanding the adoption of personalized healthcare solutions. This results in increased utilization of pet gut microbiome testing across companion animal healthcare.
Continuous improvements in DNA sequencing technologies and bioinformatics are making pet gut microbiome testing more accurate, accessible, and clinically useful. Enhanced analytical capabilities enable comprehensive microbial profiling, allowing veterinarians to better understand digestive health and support treatment decisions. This technological progress is increasing the availability of advanced microbiome testing solutions and driving broader market demand.
Limited Clinical Standardization and Dependence on Specialized Laboratory Infrastructure Restrain Market Expansion
The absence of universally accepted reference standards and clinical guidelines for interpreting pet microbiome data creates variability in test results and treatment recommendations. This reduces confidence among veterinarians regarding the routine clinical application of microbiome testing and slows its integration into standard veterinary practice. Consequently, limited clinical standardization acts as a key restraint on the adoption of pet gut microbiome testing.
Pet gut microbiome testing relies on specialized sequencing laboratories, cold-chain sample handling, and advanced bioinformatics capabilities that are not widely available in all regions. Delays in sample transportation and limited access to accredited testing facilities can increase turnaround times and operational costs. Consequently, dependence on specialized laboratory infrastructure and logistics remains a significant restraint on the expansion of the pet gut microbiome testing market.
Growing Use of Microbiome Biomarkers and Expansion into Livestock and Equine Microbiome Diagnostics Open New Avenues for Market Players
Pharmaceutical companies, contract research organizations, and veterinary diagnostic laboratories are increasingly utilizing gut microbiome biomarkers to support veterinary drug discovery and clinical research. Microbiome profiling enables better patient stratification, treatment monitoring, and evaluation of therapeutic responses in companion animals. As microbiome-based therapeutics and precision veterinary medicine continue to evolve, demand for validated microbiome testing services and large-scale microbial datasets is expected to increase, creating long-term growth opportunities for market participants.
While current adoption is concentrated in companion animals, microbiome testing providers have significant opportunities to expand into horses and livestock, where gut health directly influences productivity, feed efficiency, and disease management. This creates growth opportunities for veterinary diagnostics companies, agricultural biotechnology firms, and animal health laboratories. As precision livestock farming gains momentum, microbiome testing is expected to become a valuable management tool across commercial animal production.
Limited Availability of Long-Term Datasets and Variability in Pet Owners Compliance Challenges Market Growth
A major challenge for the market is the limited availability of long-term microbiome datasets that correlate microbial changes with disease progression, treatment response, and lifelong health outcomes in companion animals. Without robust longitudinal evidence, it is difficult to develop predictive diagnostic models and strengthen clinical confidence. This slows product innovation and limits broader adoption of microbiome testing in preventive veterinary care.
Obtaining high-quality fecal samples depends on proper collection, storage, and timely shipment by pet owners, making pre-analytical variability a persistent challenge. Improper handling can compromise microbial integrity, resulting in inconclusive or inconsistent test outcomes and increasing repeat testing costs.
The test kits segment accounted for a share of 57.24% in 2025, owing to widespread preference for at-home fecal sample collection, standardized sampling protocols, and convenient mail-in diagnostic workflows. These kits enable consistent specimen quality while reducing clinic visits, making microbiome testing more accessible for companion animal owners.
The services segment is expected to grow at a CAGR of around 7.19% during the forecast period, driven by the increasing demand for advanced bioinformatics interpretation, microbiome consultation, and customized health reporting. Veterinary professionals increasingly rely on expert analytical services to translate complex sequencing data into actionable clinical recommendations.
The dogs segment accounted for a share of 38.85% in 2025 due to higher incidence of gastrointestinal disorders, frequent probiotic usage, and increasing enrollment in preventive wellness programs. Dog owners are more likely to seek microbiome testing for digestive optimization and long-term health monitoring.
The cats segment is expected to grow at a CAGR of 7.52% during the forecast period, fueled by increasing recognition of chronic digestive sensitivity, food intolerance management, and microbiome supported dietary interventions. Growing feline healthcare awareness is encouraging broader adoption of specialized gut health assessments.
The disease diagnosis segment accounted for a share of 42.25% in 2025, supported by the increasing use of microbiome profiling to investigate chronic gastrointestinal disorders, microbial dysbiosis, and recurrent digestive conditions. Veterinarians utilize these insights to support differential diagnosis alongside conventional clinical assessments.
The nutritional assessment segment is expected to grow at a CAGR of 7.36% during the forecast period, driven by rising adoption of microbiome guided dietary optimization, functional nutrition planning, and individualized supplement recommendations. Pet owners increasingly seek evidence-based nutrition strategies tailored to gut microbial composition.
The veterinary clinics & hospitals segment accounted for a share of 52.48% in 2025, as they provide direct clinical evaluation, diagnostic interpretation, and integrated treatment planning following microbiome analysis. Their established patient relationships and routine diagnostic services support higher testing volumes.
The research organization segment is expected to grow at a CAGR of 7.67% during the forecast period, driven by expanding microbiome research, increasing companion animal clinical studies, and greater investment in microbial biomarker discovery. Research institutions are generating scientific evidence supporting broader veterinary applications of microbiome testing.
North America: Market Dominance Led by Advanced Veterinary Diagnostics and High Companion Animal Healthcare Spending
The North America pet gut microbiome testing market accounted for the largest regional share of 39.04% in 2025, driven by high pet ownership, widespread adoption of advanced veterinary diagnostics, and increasing expenditure on companion animal preventive healthcare. The region benefits from a well-established veterinary infrastructure, growing awareness of personalized pet nutrition, and early adoption of microbiome-based health assessments. According to the American Pet Products Association (APPA), approximately 94 million US households owned at least one pet in 2025, supporting sustained demand for innovative veterinary diagnostic services.
The US pet gut microbiome testing market was valued at USD 108.03 million in 2025, driven by increasing adoption of preventive veterinary care, rising demand for personalized nutrition, and strong consumer spending on companion animal wellness. Veterinary clinics and diagnostic laboratories are increasingly incorporating microbiome testing into routine health assessments to support digestive health management and individualized treatment strategies. The country's extensive network of veterinary hospitals, research institutions, and pet health technology companies continues to drive the adoption of advanced microbiome diagnostics.
The Canada pet gut microbiome testing market size was valued at USD 16.14 million in 2025, supported by growing awareness of preventive pet healthcare, increasing pet insurance coverage, and rising demand for specialized veterinary diagnostic services. Companion animal owners are increasingly seeking personalized nutritional solutions and early disease detection tools to improve pet health. The country's expanding veterinary healthcare infrastructure and emphasis on evidence-based animal care continue to support the adoption of microbiome testing across veterinary clinics and diagnostic laboratories.
Asia Pacific: Fastest Growth Driven by Expanding Companion Animal Ownership and Digital Veterinary Healthcare
The Asia Pacific pet gut microbiome testing market is expected to grow at a CAGR of 8.41% during the forecast period, showcasing the fastest regional growth. Growth is supported by rapid rising companion animal ownership, increasing availability of premium veterinary services, and expanding digital pet healthcare platforms. Growing consumer awareness of preventive pet wellness is accelerating adoption of advanced diagnostics. According to the Japan Pet Food Association, Japan had approximately 15.9 million pet dogs and cats in 2025, highlighting the region's strong companion animal healthcare demand.
The China pet gut microbiome testing market was valued at USD 17.86 million in 2025, driven by rapid expansion of domestic pet healthcare ecosystems, increasing consumer preference for precision nutrition tailored to companion animals, and strong integration of digital pet service platforms with veterinary care. The growing availability of specialized veterinary diagnostic laboratories and rising demand for premium preventive healthcare solutions are accelerating microbiome testing adoption.
The India pet gut microbiome testing market was valued at USD 9.14 million in 2025, fueled by expanding organized veterinary healthcare, increasing awareness of breed-specific digestive disorders, and growing acceptance of preventive diagnostics among urban pet owners. Rising disposable incomes are encouraging expenditure on premium pet wellness services.
The Japan pet gut microbiome testing market size was valued at USD 10.54 million in 2025, supported by growing focus on extending companion animal longevity, increasing demand for evidence-based veterinary wellness solutions, and widespread adoption of premium preventive pet healthcare. The country's mature veterinary ecosystem and strong emphasis on nutritional management for aging pets are accelerating microbiome testing adoption.
The pet gut microbiome testing market competitive landscape is moderately fragmented, with a mix of specialized microbiome testing companies, veterinary diagnostic laboratories, animal health companies, and genomics technology providers competing across different segments of the value chain. Established players primarily compete through advanced sequencing capabilities, scientific validation, and broad veterinary networks. Emerging companies focus on innovative microbiome analytics, AI-driven health insights, and nutrition integration. The pet gut microbiome testing market ecosystem is also shaped by continuous research collaborations, product innovation, and expansion into new geographic markets and veterinary applications.
June 2026: AnimalBiome presented multiple new microbiome studies at the ACVIM Forum 2026, including research on antibiotic effects, fiber supplementation, fecal microbiota transplantation (FMT), and Peptacetobacter hiranonis supplementation in dogs and cats
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a Healthcare Lead with over 7 years of industry experience, specializing in Healthcare IT. She provides comprehensive market insights on digital health, electronic medical records, telehealth, and healthcare analytics. Debashree’s research supports organizations in adopting technology-driven healthcare solutions, improving patient care, and achieving operational efficiency in a rapidly transforming healthcare ecosystem.
We are featured on:
sales@straitsresearch.com